Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ajit Pal Singh
An Open-Label, Single-Treatment, Single-Period, Single Dose, Clinical Phase 1 Study to Assess the Safety and Tolerability of Tetanus Vaccine in Healthy, Adult Subjects in India
Journal of Evidence Based Medicine and Healthcare
Related publications
Open-Label Study to Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less Than 12 Weeks in Chronological Age
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Single-Dose Pharmacokinetics of Co-Crystal of Tramadol-Celecoxib: Results of a 4-Way Randomized Open-Label Phase I Clinical Trial in Healthy Subjects
British Journal of Clinical Pharmacology
Pharmacology
A First-In-Human Randomized, Double-Blind, Placebo-Controlled, Single- And Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 to Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
A Phase 1, Single-Dose, Open-Label, 5-Treatment, Crossover, Pharmacokinetic Study of Comparative Bioavailability of Epinephrine Nasal Spray and EpiPen® in Healthy Adults With Seasonal Allergies
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: A Randomized, Placebo-Controlled First-In-Human Single-Dose Escalation Study
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
An Escalating Dose Study to Assess the Safety, Tolerability and Immunogenicity of a Herpes Simplex Virus DNA Vaccine, COR-1
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects With Renal Impairment, Including End-Stage Renal Disease
Clinical Drug Investigation
Medicine
Pharmacology
Correction To: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-In-Human, Single- And Multiple-Dose Study in Healthy Volunteers
Clinical Drug Investigation
Medicine
Pharmacology
